SPX3,845.08+13.69 0.36%
DIA310.41+0.70 0.23%
IXIC11,361.85+39.61 0.35%

BRIEF-Fusion Pharmaceuticals And Niowave Announce Actinium-225 Collaboration And Supply Agreement

reuters.com · 06/10/2022 07:48
BRIEF-Fusion Pharmaceuticals And Niowave Announce Actinium-225 Collaboration And Supply Agreement

- Fusion Pharmaceuticals Inc FUSN:

  • FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

  • FUSION PHARMACEUTICALS INC - FUSION TO INVEST $5M FOR GUARANTEED ACCESS TO ACTINIUM-225 SUPPLY

  • FUSION PHARMACEUTICALS - AS PART OF AGREEMENT, WILL ALSO HAVE AN OPTION TO INVEST IN FUTURE PRODUCTION OF ACTINIUM-225 TO SCALE WITH FUSION'S NEEDS

  • FUSION PHARMACEUTICALS INC - FUSION WILL HAVE GUARANTEED ACCESS TO A PRE-DETERMINED PERCENTAGE OF NIOWAVE'S CAPACITY OF RESULTING ACTINIUM-225

  • FUSION PHARMACEUTICALS INC - FUSION WILL ALSO HAVE PREFERRED ACCESS TO ANY EXCESS SUPPLY OF ACTINIUM-225 PRODUCED

Source text for Eikon: ID:nCNWK2YYka

Further company coverage: FUSN


((reuters.briefs@thomsonreuters.com;))